Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewsWire • 01/04/24
Ekso Bionics to Participate at Centers for Medicare & Medicaid Services (CMS) Second Biannual 2023 Healthcare Common Procedure Coding System (HCPCS) Public Meeting on Wednesday, November 29GlobeNewsWire • 11/16/23
Centers for Medicare & Medicaid Services (CMS) Codifies Medicare Coverage for Ekso Indego PersonalGlobeNewsWire • 11/02/23
Ekso Bionics to Report Third Quarter 2023 Financial Results on October 26, 2023GlobeNewsWire • 10/19/23
Ekso Bionics to Participate at the H.C. Wainwright 25th Annual Global Investment ConferenceGlobeNewsWire • 09/11/23
Ekso Bionics to Report Second Quarter 2023 Financial Results on July 27, 2023GlobeNewsWire • 07/20/23
Ekso Bionics to Report First Quarter 2023 Financial Results on April 27, 2023GlobeNewsWire • 04/20/23
Ekso Bionics to Showcase Integrated Functional Electrical Stimulation for Indego Therapy at APTA MeetingGlobeNewsWire • 02/23/23
Ekso Bionics Announces Acquisition of Human Motion and Control Business Unit Including Indego® Product Line From Parker Hannifin CorporationGlobeNewsWire • 12/05/22
Ekso Bionics to Present at H.C. Wainwright 24th Annual Global Investment ConferenceGlobeNewsWire • 09/06/22
Ekso Bionics Holdings, Inc. (EKSO) CEO Steven Sherman on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 07/28/22